Rapalogix Health
Develops prescription therapeutics and skincare products for cellular longevity and skin health
$20MSeries A
Role not disclosedWP
Woodline Partners
Activity from announced rounds
Activity in this selectionUnited States · Jun 30, 2026 · Jun 1, 2026
- Rounds participated in
- 2
- Confirmed lead rounds
- — 2 roles undisclosed
- New companies
- 2 First participation on record · 0 follow-on
- Funding in participating rounds
- $39.4M 2 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
2 in this selectionCuprum Metals
Develops chemical leaching technology for copper extraction from ores and tailings
$19.4MSeries A
Role not disclosed